Clinical Trials Browser

Interventional × Margins of Excision × Genitourinary × Clear all

NCT07141121 2025-10-07

IMARHGIN

Phase NA Recruiting

Margins of Excision, Prostatic Neoplasms

NCT06398470 2025-01-10

Study to Evaluate a New Method to Detect Residual Tumours During Surgery for Prostate Cancer Using Confocal Microscopy

Phase 1/2 Completed

Margins of Excision, Prostatic Neoplasms

NCT04129606 2019-10-17

TURBT-BP

Phase NA Unknown

Margins of Excision, Urinary Bladder Neoplasms, Neoplasm Seeding, Recurrence, Wounds and Injuries

NCT01460134 2018-01-31

A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Phase 1 Completed

DermatologicGenitourinaryGynecologicLymphoidOther hematologic neoplasmThoracic

Margins of Excision, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Ovarian Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT00719264 2017-03-20

Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer

Phase 2 Completed

365 enrolled 14 charts

Margins of Excision, Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell

NCT02260349 2016-03-10

Interest of Indocyanine Green in Neoplastic Prostatic Tissue

Phase 3 Withdrawn

Margins of Excision, Prostatic Neoplasms

NCT02460861 2015-06-03

iPROLOGX

Phase NA Unknown

Margins of Excision, Prostatic Neoplasms